Fabry disease is not one symptom. It is a constellation of problems that can affect almost every organ system in the body. This happens because the underlying cause, the buildup of a fatty substance called GL-3, is not limited to one tissue or one organ. It accumulates wherever blood vessels and cells are, which is everywhere. Understanding which organs are affected, and how, is essential for patients managing their health and for caregivers supporting someone they love.

Which Organs Does Fabry Disease Affect?

Fabry disease can affect the kidneys, heart, nervous system, gastrointestinal tract, skin, eyes, ears, and brain. The buildup of GL-3 in blood vessel walls causes progressive damage across all of these systems over time. Not every patient experiences every organ complication, and the timeline and severity vary significantly between individuals.

GL-3 accumulates inside the cells lining blood vessels throughout the body. Because blood vessels are present in every organ, the damage from Fabry disease is systemic. The organs most commonly and most seriously affected are the kidneys, the heart, and the nervous system, but the gastrointestinal tract, skin, hearing, eyes, and brain are also frequently involved.

The pace and pattern of organ involvement depends on several factors: the specific GLA mutation, the level of residual enzyme activity, whether the patient is male or female, and whether treatment was started early. Early diagnosis and treatment can slow progression significantly in all affected organs.

The Nervous System: Pain, Heat Intolerance, and Fatigue

The nervous system is among the first systems affected in classic Fabry disease. GL-3 accumulates in and around the small nerve fibres in the hands and feet, causing neuropathic pain, heat, and exercise intolerance due to impaired sweating and fatigue. These symptoms are often the earliest indicators of the disease.

1. Neuropathic Pain (Acroparesthesia)

The burning, stabbing pain in the hands and feet that defines early Fabry disease is caused by GL-3 damaging the small nerve fibres in those areas. Patients describe it as walking on broken glass, or feeling like their hands and feet are constantly on fire. This pain can be present at a low level continuously, with episodes of severe crisis pain triggered by heat, exercise, fever, illness, or stress. Crisis episodes can last hours to days and have brought many patients to emergency rooms where staff have no knowledge of Fabry disease.

In children with classic Fabry disease, this pain is almost universally attributed to growing pains. In adults, it is frequently dismissed as fibromyalgia, anxiety, or a psychiatric condition. It is none of these things. It is measurable, it is real, and it is one of the most important early warning signs of Fabry disease.

2. Heat and Exercise Intolerance

GL-3 accumulates in the sweat glands, damaging the body's ability to regulate temperature. Many patients with Fabry disease cannot sweat normally, a condition called anhidrosis or hypohidrosis. This means exercise, heat, and warm environments can rapidly become dangerous. Patients describe avoiding sunlight, refusing to work in warm spaces, and sitting out activities that other people take for granted. For children, this is isolating. For adults, it can affect employment, relationships, and quality of life significantly.

3. Fatigue

Profound fatigue is nearly universal in Fabry disease and is one of the most consistently underestimated symptoms. It is not ordinary tiredness. Patients describe it as a bone-deep exhaustion that is present regardless of how much sleep they get. It is caused by the cumulative effects of chronic pain, disrupted sleep, and the physiological burden of living with progressive multi-organ disease.

The Kidneys

The kidneys are one of the primary organs damaged by Fabry disease. GL-3 accumulates in kidney cells, causing progressive damage that initially appears as protein in the urine and, over years, advances toward kidney failure in untreated patients. Kidney disease has historically been the leading cause of premature death in men with classic Fabry disease.

Kidney involvement in Fabry disease typically begins silently. The first sign is proteinuria, the presence of protein in the urine, which usually appears in the teenage years or early adulthood in classic Fabry. This is often missed because it requires a specific urine test and does not cause noticeable symptoms.

Without treatment, GL-3 accumulation in kidney cells causes progressive scarring and declining kidney function. In untreated men with classic Fabry disease, end-stage kidney disease requiring dialysis or transplantation has historically occurred by the 30s or 40s. Enzyme replacement therapy, started early, can significantly slow this progression.

In late-onset Fabry disease, kidney involvement may be the only or primary manifestation. Progressive unexplained kidney disease in an adult, particularly with a family history of kidney failure, warrants investigation for Fabry disease.

The Heart

Cardiac involvement is the most common cause of death in Fabry patients today. GL-3 accumulates in heart muscle cells, causing the walls of the heart to thicken. This leads to arrhythmias, heart failure, and sudden cardiac death. Cardiac Fabry is also the most common form of late-onset Fabry disease.

The heart muscle accumulates GL-3 over time, causing a gradual thickening of the heart walls, most commonly the left ventricle. This condition, called left ventricular hypertrophy, impairs the heart's ability to pump blood efficiently. It also creates an unstable electrical environment in the heart, increasing the risk of arrhythmias, including atrial fibrillation and potentially fatal ventricular arrhythmias.

In late-onset Fabry disease, cardiac involvement is frequently the presenting or only sign of the condition. Research suggests that between 1 and 4 per cent of patients evaluated for unexplained left ventricular hypertrophy may have undiagnosed Fabry disease. Cardiologists evaluating unexplained LVH in adults, particularly those with a family history of heart disease or unexplained deaths, should consider Fabry disease in their differential.

Fabry disease is also associated with an increased risk of atrial fibrillation, conduction abnormalities, and sudden cardiac death. Regular cardiac monitoring, including echocardiography and cardiac MRI, is a standard part of management for all diagnosed Fabry patients.

The Gastrointestinal Tract

Gastrointestinal symptoms affect an estimated 50 to 70 per cent of patients with Fabry disease. Abdominal pain, cramping, nausea, diarrhoea, and bloating are common, often severely disruptive, and frequently misdiagnosed as irritable bowel syndrome or Crohn's disease.

GL-3 accumulation in the cells of the gastrointestinal tract causes dysfunction across the entire digestive system. Symptoms include abdominal cramping, particularly after eating, diarrhoea, nausea, bloating, and early satiety. Some patients modify their diet dramatically to manage unpredictable symptoms. Many are diagnosed with irritable bowel syndrome or Crohn's disease for years before Fabry is considered.

Gastrointestinal symptoms in Fabry disease do not always improve on enzyme replacement therapy, and additional symptomatic management is often required alongside disease-specific treatment.

Stroke and the Brain

Fabry disease significantly increases stroke risk, including in young adults. Strokes in patients with Fabry can occur as early as the 20s or 30s. Research suggests that approximately 4 to 5 per cent of young adult strokes with no identified cause may be due to undiagnosed Fabry disease.

GL-3 accumulation in the walls of blood vessels in the brain leads to a pattern of small vessel disease and an increased risk of both ischaemic stroke (caused by a blocked blood vessel) and, less commonly, haemorrhagic stroke. The mechanism is distinct from common causes of stroke such as atherosclerosis, which is why Fabry-related strokes can occur at unusually young ages in people with no traditional cardiovascular risk factors.

If you or a family member has experienced a stroke at a young age with no clear cause, Fabry disease is worth investigating, particularly where there is also unexplained kidney disease, cardiac thickening, or a family history of similar events.

Skin, Eyes, and Hearing

Several external signs of Fabry disease can appear on the skin, eyes, and in the ears. These include angiokeratomas on the skin, a distinctive corneal pattern called cornea verticillata, and progressive high-frequency hearing loss. None of these alone is diagnostic of Fabry disease, but together they form a recognisable clinical picture.

Angiokeratomas are small, dark red to purple raised spots on the skin, typically appearing in clusters around the hips, groin, navel, and upper thighs. They are caused by GL-3 accumulation in the small blood vessels in the skin and are present in the majority of patients with classic Fabry disease.

Cornea verticillata is a whorl-like pattern visible on the cornea under slit lamp examination, present in most patients with Fabry disease. It does not affect vision and is often discovered incidentally by ophthalmologists. It is a useful diagnostic clue that is frequently overlooked because clinicians not familiar with Fabry disease do not know what they are looking at.

Progressive high-frequency hearing loss affects many patients with Fabry disease and can begin at a relatively young age. Tinnitus and vertigo are also commonly reported. Regular hearing assessments are recommended for all diagnosed patients.